ESSILOR (EPA:EL) ESSILOR - Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2010
Transparency directive : regulatory news
08/03/2010 18:05
Click here to download pdf version
Regulatory Information
Disclosure of Share Capital and Voting Rights
Outstanding as of February 28, 2010
(Pursuant to Article L.233-8 II of the
French Commercial Code and articles 221-1 and 223-16 of the General Regulations
of the Autorité des Marchés Financiers)
Charenton-le-Pont, France (March 08,
2010 - 06:00 pm) - As of February 28, shares and voting rights outstanding of
Essilor, the world leader in ophthalmic optics, broke down as follows:
February 28, 2010
Shares outstanding 215,752,030
Exercisable voting rights 228,592,320
Total potential voting rights, including rights attached 234,053,357
to shares held in treasury and under the liquidity contract.
The world leader in ophthalmic optical products, Essilor International
researches, develops, manufactures and markets around the world a wide range
of lenses to correct myopia, hyperopia, presbyopia and astigmatism. Its
flagship brands are Varilux(r), Crizal(r), Essilor(r), Definity(r) and
Xperio(TM). Based in France, the company reported consolidated revenue of
EUR3.2 billion in 2009, with 34,700 employees and operations in 100 countries.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in
the CAC 40 index. Codes and symbols: ISIN: FR FR0000121667;
Reuters: ESSI.PA; Bloomberg: EI:FP.
Investor Relations and Financial Communications
www.essilor.com
Phone: +33 (0)1 49 77 42 16